المؤلفون: Inoue H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.; Division of Gastroenterology, Shiga University of Medical Science, Setatsukinowa-tyou, Otsu, Shiga, 520-2192, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan. k.yamazaki@scchr.jp., Fushiki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Shirasu H; Division of Medical Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Kawakami T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Machida N; Division of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan., Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Onozawa Y; Division of Medical Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan., Andoh A; Division of Gastroenterology, Shiga University of Medical Science, Setatsukinowa-tyou, Otsu, Shiga, 520-2192, Japan., Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.

المصدر: Investigational new drugs [Invest New Drugs] 2021 Oct; Vol. 39 (5), pp. 1399-1404. Date of Electronic Publication: 2021 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Biliary Tract Neoplasms/*drug therapy , Cisplatin/*therapeutic use , Deoxycytidine/*analogs & derivatives , Oxonic Acid/*therapeutic use , Tegafur/*therapeutic use, Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biliary Tract Neoplasms/mortality ; Biliary Tract Neoplasms/pathology ; Cisplatin/administration & dosage ; Cisplatin/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Drug Combinations ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Oxonic Acid/administration & dosage ; Oxonic Acid/adverse effects ; Retrospective Studies ; Tegafur/administration & dosage ; Tegafur/adverse effects ; Gemcitabine

المؤلفون: Matsumoto I; Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan. Electronic address: ippeimm@gmail.com., Kamei K; Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan., Omae K; Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan., Suzuki S; Department of Clinical Oncology, Yamagata University Hospital, Yamagata, Japan., Matsuoka H; University of Occupational and Environmental Health, Fukuoka, Japan., Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan., Ozaka M; Department of Gastroenterology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Kobayashi S; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Kanagawa, Japan., Uesugi K; Department of Gastroenterology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan., Kobayashi M; Clinical Trial Promotion Section, Shizuoka Industrial Foundation Pharma Valley Center, Shizuoka, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2019 Mar; Vol. 19 (2), pp. 296-301. Date of Electronic Publication: 2019 Jan 04.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 100966936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1424-3911 (Electronic) Linking ISSN: 14243903 NLM ISO Abbreviation: Pancreatology

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*drug therapy, Adenocarcinoma/epidemiology ; Adenocarcinoma/genetics ; Adult ; Aged ; Female ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/therapeutic use ; Japan/epidemiology ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Oxaliplatin/therapeutic use ; Pancreatic Neoplasms/epidemiology ; Pancreatic Neoplasms/genetics ; Prognosis

المؤلفون: Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. Electronic address: h.taniguchi@aichi-cc.jp., Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Komori A; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Kito Y; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ishihara M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Tanaka T; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ando M; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Onozawa Y; Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Tajika M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Mori K; Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2017 Jun; Vol. 16 (2), pp. e15-e22. Date of Electronic Publication: 2016 Aug 31.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Colorectal Neoplasms/*drug therapy , Phenylurea Compounds/*administration & dosage , Pyridines/*administration & dosage , Trifluridine/*administration & dosage , Uracil/*analogs & derivatives, Aged ; Antineoplastic Agents/adverse effects ; Cohort Studies ; Colorectal Neoplasms/pathology ; Disease-Free Survival ; Drug Combinations ; Female ; Humans ; Japan ; Male ; Middle Aged ; Neoplasm Metastasis ; Phenylurea Compounds/adverse effects ; Pyridines/adverse effects ; Pyrrolidines ; Retrospective Studies ; Survival Rate ; Thymine ; Treatment Outcome ; Trifluridine/adverse effects ; Uracil/administration & dosage ; Uracil/adverse effects

المؤلفون: Hamauchi S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan. Electronic address: k.yamazaki@scchr.jp., Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Kito Y; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Komori A; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Tsushima T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Narita Y; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Todaka A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ishihara M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Tanaka T; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Onozawa Y; Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Ando M; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Tajika M; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Mori K; Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2017 Mar; Vol. 16 (1), pp. 51-57. Date of Electronic Publication: 2016 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Colorectal Neoplasms/*drug therapy , Neutropenia/*chemically induced , Trifluridine/*adverse effects , Uracil/*analogs & derivatives, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Colorectal Neoplasms/secondary ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Pyrrolidines ; Retrospective Studies ; Thymine ; Trifluridine/administration & dosage ; Uracil/administration & dosage ; Uracil/adverse effects

المؤلفون: Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Iida Y, Ogawa H, Kamijo T, Onozawa Y, Todaka A, Hamauchi S, Onoe T, Nakagawa M, Yurikusa T, Tanuma A, Yamashita A, Nishimura T, Yasui H, Onitsuka T

المصدر: Oncology [Oncology] 2016; Vol. 91 (2), pp. 78-84. Date of Electronic Publication: 2016 Jun 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0232 (Electronic) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Squamous Cell/*secondary , Carcinoma, Squamous Cell/*therapy , Lymph Nodes/*pathology , Tongue Neoplasms/*pathology , Tongue Neoplasms/*therapy, Aged ; Antimetabolites, Antineoplastic/therapeutic use ; Chemoradiotherapy, Adjuvant ; Chemotherapy, Adjuvant ; Cisplatin/therapeutic use ; Drug Combinations ; Female ; Humans ; Lymph Nodes/surgery ; Lymphatic Metastasis ; Male ; Middle Aged ; Neck Dissection ; Neoplasm Staging ; Oxonic Acid/therapeutic use ; Patient Care Team ; Postoperative Care ; Prognosis ; Radiotherapy, Adjuvant ; Retrospective Studies ; Survival Rate ; Tegafur/therapeutic use

المؤلفون: Taniguchi, Hiroya, Yamazaki, Kentaro, Masuishi, Toshiki, Kawakami, Takeshi, Onozawa, Yusuke, Honda, Kazunori, Kadowaki, Shigenori, Narita, Yukiya, Tsushima, Takahiro, Hamauchi, Satoshi, Todaka, Akiko, Yokota, Tomoya, Ando, Masashi, Mori, Keita, Shirasu, Hiromichi, Yasui, Hirofumi, Muro, Kei

المصدر: Oncologist; Nov2023, Vol. 28 Issue 11, pe1108-e1113, 6p

مصطلحات موضوعية: DRUG efficacy, EXPERIMENTAL design, CLINICAL trials, DRUG dosage, DEOXYRIBONUCLEOSIDES, CANCER chemotherapy, IRINOTECAN, METASTASIS, ANTINEOPLASTIC agents, NEUTROPENIA, COLORECTAL cancer, CANCER patients, TREATMENT delay (Medicine), RESEARCH funding, DRUG therapy, DESCRIPTIVE statistics, BEVACIZUMAB, TERMINATION of treatment, PROGRESSION-free survival, PATIENT safety, LONGITUDINAL method, DRUG toxicity, OVERALL survival, EVALUATION

المؤلفون: Ohwada, Sae, Todaka, Akiko, Nakase, Hiroshi, Shirasu, Hiromichi, Kawakami, Takeshi, Hamauchi, Satoshi, Tsushima, Takahiro, Yokota, Tomoya, Onozawa, Yusuke, Yasui, Hirofumi, Yamazaki, Kentaro

المصدر: Investigational New Drugs; Oct2022, Vol. 40 Issue 5, p1106-1116, 11p

مصطلحات موضوعية: PANCREATIC tumors, MULTIVARIATE analysis, HEALTH outcome assessment, ANTINEOPLASTIC agents, RETROSPECTIVE studies, NEUTROPENIA, NEUTROPHIL lymphocyte ratio, SURVIVAL analysis (Biometry), PACLITAXEL, PROGRESSION-free survival, PATIENT safety, LONGITUDINAL method, DISEASE risk factors, EVALUATION, OLD age

المؤلفون: Kobayashi, Satoshi, Suzuki, Motoko, Ueno, Makoto, Maruki, Yuta, Okano, Naohiro, Todaka, Akiko, Ozaka, Masato, Tsuji, Kunihiro, Shioji, Kazuhiko, Doi, Keitaro, Kojima, Yasushi, Tsumura, Hidetaka, Tanaka, Kazunari, Higuchi, Hajime, Kawabe, Ken, Imaoka, Hiroshi, Yamashita, Tatsuya, Miwa, Haruo, Nagano, Hiroaki, Arima, Shiho

المصدر: Oncologist; Oct2022, Vol. 27 Issue 10, pe774-e782, 9p, 1 Diagram, 3 Charts, 3 Graphs

مصطلحات موضوعية: THERAPEUTIC use of antineoplastic agents, PANCREATIC tumors, ALBUMINS, DRUG efficacy, SCIENTIFIC observation, CONFIDENCE intervals, ANTINEOPLASTIC agents, GERIATRIC assessment, CANCER patients, COMPARATIVE studies, SURVIVAL analysis (Biometry), DESCRIPTIVE statistics, PACLITAXEL, PROGRESSION-free survival, LONGITUDINAL method, EVALUATION, OLD age

مصطلحات جغرافية: JAPAN

المؤلفون: Kawakami, Takeshi, Machida, Nozomu, Yasui, Hirofumi, Kawahira, Masahiro, Kawai, Sadayuki, Kito, Yosuke, Yoshida, Yukio, Hamauchi, Satoshi, Tsushima, Takahiro, Todaka, Akiko, Yokota, Tomoya, Yamazaki, Kentaro, Fukutomi, Akira, Onozawa, Yusuke

المصدر: Cancer Chemotherapy & Pharmacology; Oct2016, Vol. 78 Issue 4, p809-814, 6p

مصطلحات موضوعية: IRINOTECAN, DRUG efficacy, MEDICATION safety, STOMACH cancer treatment, TAXANES, THERAPEUTICS, ANTINEOPLASTIC agents, CAMPTOTHECIN, DRUG administration, PROGNOSIS, STOMACH tumors, SURVIVAL analysis (Biometry), TREATMENT effectiveness, RETROSPECTIVE studies, KAPLAN-Meier estimator